Cargando…

Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies

BACKGROUND: Serum procalcitonin (PCT) and C-reactive protein (CRP) are biomarkers of infection. In patients with hematologic disorders with or without hematopoietic stem cell transplantation (HSCT), it is difficult to distinguish bloodstream infections from aseptic causes of febrile episodes. The ob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Mina, Choi, Seung Jun, Lee, Jaewoong, Lee, Dong Gun, Kim, Yoon-Joo, Park, Yeon-Joon, Oh, Eun-Jee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903763/ https://www.ncbi.nlm.nih.gov/pubmed/31821331 http://dx.doi.org/10.1371/journal.pone.0225765

Ejemplares similares

The Usefulness of Procalcitonin and C-Reactive Protein as Early Diagnostic Markers of Bacteremia in Cancer Patients with Febrile Neutropenia
por: Kim, Dae Yong, et al.
Publicado: (2011)

Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children
por: Han, Seung Beom, et al.
Publicado: (2013)

Utility of Procalcitonin as an Early Diagnostic Marker of Bacteremia in Patients with Acute Fever
por: Kim, Myeong Hee, et al.
Publicado: (2011)

Serum procalcitonin as a diagnostic marker of neonatal sepsis
por: Park, In Ho, et al.
Publicado: (2014)

Procalcitonin Is a Marker of Gram-Negative Bacteremia in Patients With Sepsis
por: Guo, Shun Yuan, et al.
Publicado: (2015)

The role of procalcitonin in febrile patients
por: Hatipoglu, Mustafa, et al.
Publicado: (2015)

Procalcitonin and C-Reactive Protein As Markers of Bacteremia in Patients With Febrile Neutropenia Who Receive Chemotherapy for Acute Leukemia: A Prospective Study From Nepal
por: Shilpakar, Ramila, et al.
Publicado: (2019)

Prevalence and clinical course of upper airway respiratory virus infection in critically ill patients with hematologic malignancies
por: Lee, Jongmin, et al.
Publicado: (2021)

Can procalcitonin reflect the etiology of the bacteremia?
por: Chernevskaya, Ekaterina, et al.
Publicado: (2007)

The Clinical Impact of Daptomycin Non-susceptible Enterococcus Bacteremia in Hematologic Malignancy
por: Lee, Rachael A, et al.
Publicado: (2017)

Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients
por: Koizumi, Yusuke, et al.
Publicado: (2017)

Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode
por: Demirel, Aslıhan, et al.
Publicado: (2015)

Serum procalcitonin as a diagnostic tool of bacteremia
por: Gartzonika, C, et al.
Publicado: (2010)

Predictive factors for bacteremia in febrile infants with urinary tract infection
por: Yoon, Seo Hee, et al.
Publicado: (2020)

720 Clinical Features and Risk Factors for Mortality of Stenotrophomonas maltophilia Bacteremia in Patients with Hematologic Malignancies
por: Cho, Sun Young, et al.
Publicado: (2014)

Bacteremia in febrile cancer patients in Uganda
por: Lubwama, Margaret, et al.
Publicado: (2019)

Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department
por: Hausfater, Pierre, et al.
Publicado: (2007)

Procalcitonin as a potent marker of bacterial infection in febrile Afro-Caribbean patients at the emergency department
por: Limper, M., et al.
Publicado: (2011)

Antibiotic-Resistant Gram-Negative Bacteremia in Febrile Neutropenic Children
por: Lee, Jina
Publicado: (2016)

Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China
por: Yuan, Wei, et al.
Publicado: (2016)

Procalcitonin (PCT) and C-reactive Protein (CRP) as severe systemic infection markers in febrile neutropenic adults
por: Massaro, Karin SR, et al.
Publicado: (2007)

Procalcitonin may not be a differential diagnostic marker for bacterial infection in febrile patients with chronic gouty arthritis
por: Zhang, Jing, et al.
Publicado: (2018)

Risk factors for bacteremia in children with febrile neutropenia
por: KARA, Soner Sertan, et al.
Publicado: (2019)

Usefulness of the procalcitonin test in young febrile infants between 1 and 3 months of age
por: Lee, In Sul, et al.
Publicado: (2018)

Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2014)

The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies
por: Çalık, Şebnem, et al.
Publicado: (2018)

Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
por: Álvarez, José C., et al.
Publicado: (2021)

Cap-Independent Translation in Hematological Malignancies
por: Horvilleur, Emilie, et al.
Publicado: (2015)

Procalcitonin and C-reactive protein in differantiating to contamination from bacteremia
por: Oksuz, Lutfiye, et al.
Publicado: (2015)

Diagnostic Value of Procalcitonin in Predicting Bacteremia in Intensive Care Unit
por: Demirdal, Tuna, et al.
Publicado: (2018)

Diagnostic Value of Procalcitonin in Predicting Bacteremia in Intensive Care Unit
por: Patnaik, Rupali, et al.
Publicado: (2018)

Procalcitonin levels in candidemia versus bacteremia: a systematic review
por: Cortegiani, Andrea, et al.
Publicado: (2019)

Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study
por: Kim, Hyo Sup, et al.
Publicado: (2017)

Integrative omics to detect bacteremia in patients with febrile neutropenia
por: Kelly, Rachel S., et al.
Publicado: (2018)

Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity
por: Chong, Yong, et al.
Publicado: (2013)

Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients
por: Lakshmaiah, Kuntegowdanahalli C, et al.
Publicado: (2015)

Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
por: Álvarez, José C, et al.
Publicado: (2013)

Corrigendum to “Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update”
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2019)

Remote Monitoring of Patients With Hematologic Malignancies at High Risk of Febrile Neutropenia: Exploratory Study
por: Kroloff, Maxwell, et al.
Publicado: (2022)

Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia
por: Tsai, Ching-Yen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5dm5mvniru3hro2n2remkt2bsp